DB:CYX

Stock Analysis Report

Executive Summary

Cardlytics, Inc. operates a purchase intelligence platform in the United States and the United Kingdom.

Snowflake

Fundamentals

High growth potential with adequate balance sheet.

Risks

  • Cardlytics has significant price volatility in the past 3 months.

Similar Companies

Share Price & News

How has Cardlytics's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-6.6%

DB:CYX

-0.2%

DE Media

1.5%

DE Market


1 Year Return

-0.2%

DB:CYX

-19.8%

DE Media

-5.8%

DE Market

CYX outperformed the Media industry which returned -19.7% over the past year.

CYX outperformed the Market in Germany which returned -7.4% over the past year.


Share holder returns

CYXIndustryMarket
7 Day-6.6%-0.2%1.5%
30 Day7.7%9.4%1.3%
90 Day50.8%11.5%2.2%
1 Year-0.2%-0.2%-15.3%-19.8%-2.8%-5.8%
3 Yearn/a-15.4%-27.9%28.8%17.6%
5 Yearn/a1.3%-20.4%26.2%8.7%

Price Volatility Vs. Market

How volatile is Cardlytics's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Cardlytics undervalued based on future cash flows and its price relative to the stock market?

11.42x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Unable to calculate intrinsic value for Cardlytics to establish if it is available at moderate discount.

Unable to calculate intrinsic value for Cardlytics to establish if it is available at substantial discount.


Price Based on Earnings

Cardlytics is loss making, we can't compare its value to the DE Media industry average.

Cardlytics is loss making, we can't compare the value of its earnings to the Germany market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Cardlytics, we can't assess if its growth is good value.


Price Based on Value of Assets

Cardlytics is overvalued based on assets compared to the DE Media industry average.


Next Steps

Future Growth

How is Cardlytics expected to perform in the next 1 to 3 years based on estimates from 7 analysts?

66.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Cardlytics's revenue is expected to grow significantly at over 20% yearly.

Cardlytics's earnings are expected to grow significantly at over 20% yearly.

Cardlytics's revenue growth is expected to exceed the Germany market average.

Cardlytics's earnings growth is expected to exceed the Germany market average.

Cardlytics's earnings growth is expected to exceed the low risk savings rate of 0.2%.


Earnings per Share Growth Estimates


Future Return on Equity

Unable to establish if Cardlytics will efficiently use shareholders’ funds in the future without estimates of Return on Equity.


Next Steps

Past Performance

How has Cardlytics performed over the past 5 years?

11.6%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Cardlytics does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.

Unable to compare Cardlytics's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Cardlytics's 1-year growth to the DE Media industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Cardlytics has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Cardlytics has efficiently used its assets last year compared to the DE Media industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Cardlytics improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Cardlytics's financial position?


Financial Position Analysis

Cardlytics is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Cardlytics's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Cardlytics's level of debt (99%) compared to net worth is high (greater than 40%).

Unable to establish if Cardlytics's debt level has increased without past 5-year debt data.


Balance Sheet

Low level of unsold assets.

Debt is covered by short term assets, assets are 2.5x debt.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Cardlytics has sufficient cash runway for 1.3 years based on current free cash flow.

Cardlytics has sufficient cash runway for 1.3 years if free cash flow continues to reduce at historical rates of -0.2% each year.


Next Steps

Dividend

What is Cardlytics's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Cardlytics's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Cardlytics's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Cardlytics has not reported any payouts.

Unable to verify if Cardlytics's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Cardlytics has not reported any payouts.


Future Payout to Shareholders

No need to calculate the sustainability of Cardlytics's dividends in 3 years as they are not expected to pay a notable one for Germany.


Next Steps

Management

What is the CEO of Cardlytics's salary, the management and board of directors tenure and is there insider trading?

4.5yrs

Average management tenure


CEO

Scott Grimes (55yo)

11.0yrs

Tenure

US$2,148,965

Compensation

Mr. Scott D. Grimes has been Director of Westar Energy, Inc. since June 4, 2018. Mr. Grimes has been Senior Vice President of Risk and Operations at Wallaby Financial, Inc., since July 09, 2014. Mr. Grimes ...


CEO Compensation Analysis

Scott's remuneration is higher than average for companies of similar size in Germany.

Scott's compensation has increased whilst company is loss making.


Management Age and Tenure

4.5yrs

Average Tenure

49.5yo

Average Age

The tenure for the Cardlytics management team is about average.


Board Age and Tenure

7.8yrs

Average Tenure

55yo

Average Age

The tenure for the Cardlytics board of directors is about average.


Insider Trading

No 3 month individual insider trading information.


Recent Insider Transactions

Sell€2,259,79011 Jun 19
Polaris Partners
EntityCompany
Shares100,000
Max Price€22.60
Sell€1,606,36207 Jun 19
Polaris Partners
EntityCompany
Shares75,284
Max Price€22.41
Sell€2,061,44931 May 19
Polaris Partners
EntityCompany
Shares100,000
Max Price€20.61
Sell€3,216,50314 Sep 18
Polaris Partners
EntityCompany
Shares150,000
Max Price€22.62
Sell€21,75921 Aug 18
Kirk Somers
EntityIndividual
Role
Chief Legal & People Officer and Secretary
Shares1,202
Max Price€18.10
Sell€24,42021 Aug 18
Lynne Laube
EntityIndividual
Role
Co-Founder
Member of the Board of Directors
Shares1,349
Max Price€18.10
Sell€26,15821 Aug 18
Scott Grimes
EntityIndividual
Role
Co-Founder
Member of the Board of Directors
Shares1,445
Max Price€18.10
Sell€21,68721 Aug 18
David Evans
EntityIndividual
Role
CFO & Head of Corporate Development
Shares1,198
Max Price€18.10

Ownership Breakdown


Management Team

  • Kirk Somers (53yo)

    Chief Legal & People Officer and Secretary

    • Tenure: 4.9yrs
  • Scott Grimes (55yo)

    Co-Founder

    • Tenure: 11.0yrs
    • Compensation: $2.15m
  • Jared Luskin

    • Tenure: 0.3yrs
  • David Evans

    CFO & Head of Corporate Development

    • Tenure: 2.7yrs
    • Compensation: $2.17m
  • Megan McKean (36yo)

    Senior Vice President of Advertiser Services

    • Tenure: 3.1yrs
  • Craig Snodgrass (45yo)

    Chief Data Officer

    • Tenure: 5.4yrs
  • Sathish Gaddipati (51yo)

    Chief Technology Officer

    • Tenure: 2.4yrs
  • Dani Cushion (40yo)

    Chief Marketing Officer

    • Tenure: 4.1yrs
  • Jim Tietz (55yo)

    Chief Revenue Officer & President of Advertising

    • Tenure: 8.5yrs
  • Lynne Laube (48yo)

    Co-Founder

    • Tenure: 11.0yrs
    • Compensation: $2.12m

Board Members

  • Dave Adams (62yo)

    Director

    • Tenure: 7.8yrs
    • Compensation: $282.50k
  • Scott Grimes (55yo)

    Co-Founder

    • Tenure: 11.0yrs
    • Compensation: $2.15m
  • Jack Klinck (54yo)

    Independent Director

    • Tenure: 2.7yrs
    • Compensation: $187.50k
  • Mark Johnson (65yo)

    Director

    • Tenure: 8.7yrs
    • Compensation: $183.75k
  • Tony Weisman (58yo)

    Director

    • Tenure: 4.7yrs
    • Compensation: $180.00k
  • John Balen (55yo)

    Chairman

    • Tenure: 2.2yrs
    • Compensation: $202.50k
  • Bryce Youngren

    Director

    • Tenure: 10.8yrs
    • Compensation: $195.00k
  • Lynne Laube (48yo)

    Co-Founder

    • Tenure: 11.0yrs
    • Compensation: $2.12m
  • Aimée Lapic (48yo)

    Director

    • Tenure: 0.2yrs

Company Information

Cardlytics, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Cardlytics, Inc.
  • Ticker: CYX
  • Exchange: DB
  • Founded: 2008
  • Industry: advertising
  • Sector: media
  • Market Cap: US$538.734m
  • Listing Market Cap: US$475.810m
  • Shares outstanding: 22.57m
  • Website: Click here

Number of Employees


Location

  • Cardlytics, Inc.
  • 675 Ponce de Leon Avenue NE
  • Suite 6000
  • Atlanta
  • Georgia
  • 30308
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CDLXNasdaqGM (Nasdaq Global Market)YesCommon StockUSUSDFeb 2018
CYXDB (Deutsche Boerse AG)YesCommon StockDEEURFeb 2018

Biography

Cardlytics, Inc. operates a purchase intelligence platform in the United States and the United Kingdom. It operates in two segments, Cardlytics Direct and Other Platform Solutions. The company’s platform i ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/06/24 23:00
End of Day Share Price2019/06/24 00:00
Earnings2019/03/31
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.